Generics have to create the drug and test it for bioequivalence, usually things like time to peak serum levels and half life of metabolites - basically has to work identically to the brand name drug within some +/- % range. What I'd like to know is how you prove a GV has the same shelf life as V - 4 yrs due to our patented encapsulation process - and as previously mentioned, how do they get around that patent to start with? I used to do enhanced life testing on products where every +10C was equivalent to 1 yr of operation at room temp - you could get 4 yr results in 1 yr by running 40C hotter than nominal temps - if there's an equivalent type of sped up shelf life testing for drugs I'd like to see how you do it. The accelerated life testing I'm talking about is used to monitor chemical reactions between different materials, in my case usually a liquid inside a metal container - I think electronics are tested in a similar manner, run them hot and watch for failures. For GV you'd look for interactions between the atmosphere and the capsule contents, measure oxidation rates, but I'm not sure the same equations and techniques work for drugs, meaning simply testing at elevated temps would yield the results you're looking for - the capsule material might be fine at room temp + 30C but break down at room temp + 40C.